agilon health, inc.

AGLReported to SECin USCIK 0001831097Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 3 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

3
Form 4 lines at agilon health, inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Gertsch TimothyChief Accounting OfficerAdministrative$1,64717 sharesAug 18, 2026Gertsch TimothyChief Accounting Officer$1,647Admin · Aug 18Administrative17Aug 18, 2026
Zamore DeniseChief Legal OfficerAdministrative$3,39037 sharesAug 4, 2026Zamore DeniseChief Legal Officer$3,390Admin · Aug 4Administrative37Aug 4, 2026
Schwaneke Jeffrey A.Chief Financial OfficerAdministrative$258,2312,311 sharesJul 2, 2026Schwaneke Jeffrey A.Chief Financial Officer$258,231Admin · Jul 2Administrative2,311Jul 2, 2026

Lobbying

From the quarterly LD-2 filings at the U.S. Senate — a different register, and a different kind of fact.

This is not a trade and it is not scored. A lobbying filing says who lobbied for whom, on which issues, and for how much — it says nothing about the share price and nothing about this company’s insiders. The link between the client names in that register and agilon health, inc. is a reviewed rule of ours: an LD-2 names a client and carries no ticker, no CIK and no LEI.

Most recent quarterQ1 20252 reports counted in that quarter
Reported that quarter$60,000 reported income$130,000 reported expenseswhat the filings for that quarter state, in the words of the form
Client names2client names in the register map to this company; a company often lobbies under several

Every lobbying filing we hold for AGL

Lobbying reported per quarter

reported amounts per quarter, latest version of each report

There are two charts here because there are two different amounts. A lobbying firm reports income: what it was paid. A company that lobbies for itself reports expenses: what it spent, under one of three accounting methods it picks itself. Both appear under this company, and they are not the same measurement — so they are never added, not in a bar and not in a total.

Reported income: what lobbying firms reported receiving from this company's clients, per quarter.

Reported expenses: what this company reported spending on its own lobbying, per quarter, under the accounting method it picked itself.

Before 2025, these bars cover only the lobbying relationships that were still active in 2025 or later. Engagements that ended earlier are not included, so those years may be higher than shown.

Reported income

Q1Q2Q3Q4
$0$125k$250k2023: $20k Q1, $60k Q2, $60k Q3, $60k Q420232024: $60k Q1, $60k Q2, $60k Q3, $60k Q420242025: $60k Q12025

Reported expenses

Q1Q2Q3Q4
$0$250k$500k2023: $0 Q1, $30k Q2, $190k Q3, $120k Q420232024: $120k Q1, $120k Q2, $140k Q3, $110k Q420242025: $130k Q12025